CAS: 20784-50-3; Isobavachalcone

该化合物是一种天然化合物,被归类为一种碳酮,是一种氟氯素,主要来自Angelica keiskei植物物种,由于其潜在的药理特性而引起了兴趣;Isobavachalconne的特征是黄色晶体外观,以其各种生物活动,包括抗炎,抗氧化剂和抗癌效应而闻名;该化合物展示了一种独特的结构,其组成为苯基环和铬骨骼,有助于其再活动以及与生物系统的互动;其行动机制往往涉及信号路径的调节和特定酶的抑制;此外,对异丙烷酮在治疗各种疾病方面的潜力进行了研究,使其成为药物化学和天然产品研究的一个主题;与许多自然化合物一样,其功效和安全特征是不断调查的主题,突出了进一步研究以充分了解其治疗潜力的重要性.

结构式图片

上下游产品

2',4'-dihydroxy-4-acetophenone 2'-prenyloxy-4'-methoxymethoxyacetophenone 4,4'-bis(methoxymethoxy)-2'-prenyloxychalcone 4-methoxymethoxy-benzaldehyde(E)-1-(5-hydroxy-2,2-dimethylchroman-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

合成工艺路线路线简述

    2,4-二羟基苯乙酮置于盐酸,甲醇,(1,1'-Bis(Diphenylphosphino)Ferrocene)Palladium(II) Dichloride,Potassium Iodate,碘,Sodium Hydride,Caesium Carbonate,Potassium Hydroxide体系中,用 乙醇,二氯甲烷,水,N,N-二甲基甲酰胺 用作溶剂,化学反应 22.0H,反应生成补骨脂乙素
    参考文献:通过区域特异性碘化和suzuki偶联反应轻松合成异戊二烯基和香叶基查尔酮天然产物
    标题:通过区域特异性碘化和suzuki偶联反应轻松合成异戊二烯基和香叶基查尔酮天然产物
    摘要:四个带有异戊二烯基或香叶基的天然查耳酮,即异巴威康酮(1),巴伐卡康酮(2),黄嘌呤酚(3)和2',4',4-三羟基-5'-香叶烷基查耳酮(isoxanthoangelol,4通过使用区域选择性碘化和suzuki偶联反应作为关键步骤合成).其中,2',4',4-三羟基-5'-香叶基查尔酮的第一次总合成以36%的总收率实现.与已报道的基于c-烷基化或o-烷基化,然后进行claisen重排以引入侧链的方法相比,该新策略利用了碘化过程中宝贵的区域化学控制.前三个查耳酮的合成总产率分别从17%提高到53%,12%提高到35%,28%提高到50%.
    Doi:10.1016/j.Tetlet.2013.12.044

    海关参考信息

    专利信息


    专利号:US-2007232495-A1
    优先权日:2006-03-24
    标题:Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof
    发明人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    权利人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    摘要:The invention is related to compositions and methods that naturally protect plant tissues against ultraviolet radiation and temperature, thus giving protection against sunburn to plants, plant parts, fruits and/or flowers during their development. The invention is also related to compositions and methods to naturally improve the color of plants, plant parts, fruits and/or flowers by inducing the natural synthesis of flavonoids and anthocyanins present in plants. Likewise, the present invention is directed to improving the nutritional value of plants, plant parts, fruits and/or flowers by increasing the normal levels of polyphenolic compounds, especially flavonoids, present therein. Additionally, the present invention is related to compositions and methods that give more resistance to plants, plant parts, fruits and/or flowers against pathogens as bacteria and fungi. Finally, the present invention is related to plants, plant parts, fruits, flowers and/or propagating material treated with the compositions described in the present document.
    北京海步国际医药科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hopelife.cn
    电话: 86-10-67886402👤
    📞北京海步国际医药科技发展有限公司 ⚠️参考联系方式

    销售电话:86-10-67886402
    邮箱:apis@hopelife.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Jin X, Shi YI. Isobavachalcone induces the apoptosis of gastric cancer cells via inhibition of the Akt and Erk pathways. Exp Ther Med. 2016 Feb;11(2):403-408. Epub 2015 Dec 1.
    2: Kuete V, Mbaveng AT, Zeino M, Fozing CD, Ngameni B, Kapche GD, Ngadjui BT, Efferth T. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells. Phytomedicine. 2015 Nov 15;22(12):1096-102. doi: 10.1016/j.phymed.2015.07.006. Epub 2015 Aug 11. doi: 10.1007/s12272-015-0658-8. Epub 2015 Sep 15. doi: 10.1016/j.ejphar.2015.02.013. Epub 2015 Feb 19. doi: 10.1016/j.jpba.2014.12.023. Epub 2014 Dec 22. doi: 10.1016/j.jpba.2014.11.010. Epub 2014 Nov 15. doi: 10.1016/j.saa.2014.02.013. Epub 2014 Feb 18. doi: 10.1016/j.febslet.2013.07.037. Epub 2013 Jul 29. doi: 10.1016/j.intimp.2012.11.005. Epub 2012 Nov 16. doi: 10.3892/ijmm.2012.1066. Epub 2012 Jul 16. doi: 10.1007/s11655-012-1142-7. Epub 2012 Jul 7. Review. doi: 10.1002/jssc.201200173. doi: 10.1002/jssc.201000801. Epub 2011 Jan 25. Epub 2010 Jul 7. doi: 10.1016/j.canlet.2010.01.035. Epub 2010 Feb 18. doi: 10.1128/AAC.01533-09. Epub 2010 Feb 16.
    17: Choi JH, Rho MC, Lee SW, Choi JN, Kim K, Song GY, Kim YK. Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia. Arch Pharm Res. 2008 Nov;31(11):1419-23. doi: 10.1007/s12272-001-2126-x. Epub 2008 Nov 21.

    合成参考文献


    参考文献:10.1021/acs.jnatprod.6b00783
    摘要:Li K, Ji S, Song W, Kuang Y, Lin Y, Tang S, Cui Z, Qiao X, Yu S, Ye M. Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra. J Nat Prod. 2017 Feb 24;80(2):334–46. doi: 10.1021/acs.jnatprod.6b00783.
    参考文献:10.1016/j.ejmech.2019.06.034
    摘要:Kishore N, Kumar P, Shanker K, Verma AK. Human disorders associated with inflammation and the evolving role of natural products to overcome. European Journal of Medicinal Chemistry. 2019 Oct;179():272–309. doi: 10.1016/j.ejmech.2019.06.034.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知